Sinopharm Achieves More Contract Value at 3rd CIIE

China National Pharmaceutical Group Co., Ltd. (Sinopharm) signed contracts with higher amounts than those signed at the previous two China International Import Expo (CIIE) events.

According to the company, this year's contracts are valued at 25 percent more than those signed at last year's CIIE. Six of this year's cooperators are Fortune Global 500 enterprises.

What's more, the products involved in the contracts are expected to be the most advanced in the world and will boost efficiency of China's medical research and development while promoting the country's medical service.

In addition to the treatment facilities, Sinopharm's contracts also cover health products including Fancl's health food and Dole's health vegetables and fruits to meet people's demands for an enjoyable life.

It's worth mentioning that Luis Diego Monsalve Hoyos, Colombian ambassador to China, also attended Sinopharm's signing ceremony.

The increasing contract value of Sinopharm amid the COVID-19 epidemic shows the company's confident determination to deepen international cooperation with internationally-leading medical and healthcare firms as well as its commitment to protecting people's health.

(Executive editor: Wang Ruoting)